Remco Vellinga
Overview
Explore the profile of Remco Vellinga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vellinga R, Koomen J, Eleveld D, Stohr T, Pesic M, Struys M, et al.
Anesthesiology
. 2025 Mar;
142(4):666-679.
PMID: 40067039
Background: Synergistic effects between opioids and remimazolam on Bispectral Index (BIS) and Modified Observer's Assessment of Alertness and Sedation (MOAAS) score were previously described. This study aimed to characterize the...
2.
Vellinga R, Introna M, van Amsterdam K, Zhou X, De Smet T, Weber Jensen E, et al.
J Clin Monit Comput
. 2023 Dec;
38(2):519-529.
PMID: 38112878
This single blinded randomized controlled trial aims to assess whether the application of a Bayesian-adjusted Ce (effect-site of propofol) advisory tool leads towards a more stringent control of the cerebral...
3.
Vellinga R, Koomen J, Eleveld D, Stohr T, Pesic M, Struys M, et al.
Anesthesiology
. 2023 Oct;
140(2):207-219.
PMID: 37889844
Background: Remimazolam exhibits sedative properties by binding to γ-aminobutyric acid type A receptors. Remimazolam is administered as a bolus dose or continuous infusion, but has not been studied using target-controlled...
4.
Vellinga R, Eleveld D, Struys M, van den Berg J
Curr Opin Anaesthesiol
. 2023 Sep;
36(5):602-607.
PMID: 37678184
Purpose Of Review: There are various pharmacokinetic-dynamic models available, which describe the time course of drug concentration and effect and which can be incorporated into target-controlled infusion (TCI) systems. For...
5.
Vellinga R, Valk B, Absalom A, Struys M, Barends C
J Clin Med
. 2022 Jun;
11(12).
PMID: 35743563
New anaesthetic drugs and new methods to administer anaesthetic drugs are continually becoming available, and the development of new PK-PD models furthers the possibilities of using arget controlled infusion (TCI)...
6.
Vellinga R, Hannivoort L, Koomen J, Colin P, Absalom A, Struys M, et al.
Br J Anaesth
. 2021 May;
127(1):e3-e5.
PMID: 33934890
No abstract available.
7.
Vellinga R, Hannivoort L, Introna M, Touw D, Absalom A, Eleveld D, et al.
Br J Anaesth
. 2020 Dec;
126(2):386-394.
PMID: 33317804
Background: Target-controlled infusion (TCI) systems incorporating pharmacokinetic (PK) or PK-pharmacodynamic (PK-PD) models can be used to facilitate drug administration. Existing models were developed using data from select populations, the use...